Lab Manager | Run Your Lab Like a Business

New TOC Analyzers for the Pharma Industry Simplify Cleaning Validation and Total Protein Determination

With the multi N/C 2100S pharma and 3100 pharma, two new device models are being introduced

by Analytik Jena AG
Register for free to listen to this article
Listen with Speechify

Jena, Germany, September 26, 2019 — The TOC (total organic carbon) analyzers of the multi N/C pharma series from Analytik Jena are being expanded. With the multi N/C 2100S pharma and 3100 pharma, two new device models are being introduced. Both systems are aligned even more closely with the requirements of the pharmaceutical industry.

Analytik Jena's multi N/C 2100S pharmaAnalytik Jena's multi N/C 2100S pharma. Credit: Analytik JenaThe multi N/C 2100S pharma specializes in vaccine quality control using the measurement of total nitrogen. Thanks to the direct injection of samples, the system enables the fully automated and carryover-free processing of total protein analyses. With this TN analyzer, the quality control of vaccines can be achieved in a more time- and cost-effective manner. By contrast, the sister model multi N/C 3100 pharma is a fully automated high-throughput analyzer, which primarily performs TOC cleaning validation and the determination of extractable organic compounds (leachables) from polymer packaging in the pharmaceutical area.

Depending on the pharmacopoeias, the TOC/TN cleaning validation and TOC ultra-pure water test (i.e., WFI) can be carried out by means of high temperature combustion or wet chemical UV digestion. With the established multi N/C pharma UV and the new multi N/C 3100 pharma, customers now have a solution with a high degree of comfort in automation for both methods in the portfolio of Analytik Jena.

Get training in Lab Crisis Preparation and earn CEUs.One of over 25 IACET-accredited courses in the Academy.
Lab Crisis Preparation Course

All systems of the multi N/C pharma series are equipped with new, completely FDA-compliant software that satisfies all the data integrity requirements of the pharmaceutical industry. The multi N/C 2100S pharma and the multi N/C 3100 pharma can be seamlessly integrated with the already existing models multi N/C pharma HT for the analysis of TOC traces with high temperature combustion and the multi N/C pharma UV for the detection of traces and ultra-traces with wet chemical UV digestion.

Further information on the multi N/C pharma series can be found under